The revenue stands at ₹4,197.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.07 per cent from ₹3,303.00 crore. This corresponds to a year-on-year *(YoY) growth of 41.84 per cent.
Operating Profit stands at ₹1,290.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 19.67 per cent from ₹1,078.00 crore. This corresponds to a year-on-year *(YoY) growth of 37.23 per cent.
PBDT stands at ₹1,037.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.67 per cent from ₹1,020.00 crore. This corresponds to a year-on-year *(YoY) growth of 19.75 per cent.
Profit Before Tax stands at ₹529.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 35.01 per cent from ₹814.00 crore. This corresponds to a year-on-year *(YoY) decline of 20.45 per cent.
Net Profit stands at ₹364.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 42.68 per cent from ₹635.00 crore. This represents a 26.91 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | -3.23% | -3.89% | 3.34% | 0.53% | 17.62% | 40.35% |
| Sun Pharma.Inds. | -2.39% | -2.19% | -1.27% | 2.75% | -0.38% | 7.52% |
| Divi's Lab. | -2.02% | -1.47% | 0.63% | 4.01% | 3.71% | 1.86% |
| Cipla | -1.39% | -1.06% | 4.77% | 3.45% | -8.22% | -4.85% |
| Dr Reddy's Labs | -1.22% | -2.19% | 1.16% | 0.64% | 3.41% | 4.31% |
| Zydus Lifesci. | -0.76% | 0.43% | 19.53% | 18.84% | 15.09% | 16.01% |
Executive Chairman : Samir Mehta
Independent Director : Ameera Shah
Independent Director : Nayantara Bali
Managing Director : Aman Mehta
Independent Director : Manish Choksi
Company Sec. & Compli. Officer : Chintan Trivedi
Independent Director : Nikhil Khattau
Non Executive Director : Jindal Mehta